{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-142039","form_type":"8-K","ticker":"QTTB","cik":"0001661998","company_name":"Q32 Bio Inc.","filed_at":"2025-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.249510+00:00","generated_at":"2026-05-19T04:41:54.785944+00:00","sec_items":["3.03","5.07","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Q32 Bio stockholders approve officer exculpation charter amendment at 2025 annual meeting","bullets":["Charter amendment limiting officer liability (Delaware law) approved; effective June 16, 2025.","David Grayzel, Isaac Manke, and Diyong Xu elected Class I directors for three-year terms.","Ernst & Young ratified as independent auditor for FY 2025 with 99.9% votes for.","Say-on-pay advisory vote passed with 7.45M for; one-year frequency selected for future votes.","Adjournment proposal also approved (7.88M for) but not needed as Proposal 2 passed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-142039","json":"https://secwatch.observer/filing/0001193125-25-142039.json","markdown":"https://secwatch.observer/filing/0001193125-25-142039.md","text":"https://secwatch.observer/filing/0001193125-25-142039.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661998/000119312525142039/0001193125-25-142039-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661998/000119312525142039/d936533d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T04:41:54.785944+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8bc9cc59e82d2874f8601fa61d4f6ba38d19e887","claim":"Q32 Bio Inc.: Approved amendment to Restated Certificate of Incorporation to limit liability of certain officers as permitted by Delaware law (effective 2025-06-16).","evidence_excerpt":"on June 13, 2025 at the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of Q32 Bio Inc. (the “Company”), and upon the recommendation of the Board of Directors (the “Board”) of the Company, the Company’s stockholders approved an amendment to the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”) to limit the liability of certain officers of the Company as permitted by Delaware law (the “Charter Amendment”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661998/000119312525142039/0001193125-25-142039-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-06-16"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}